U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585331) titled 'Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance' on May 07.
Brief Summary: Through an observational clinical study, partly prospective and partly retrospective, based on the collection of clinical data and on in vitro experimental analyses carried out on residual biological samples obtained during routine clinical procedures, it is proposed to identify predictive biomarkers of in vivo response to first-line therapies.
Study Start Date: Jan. 13, 2022
Study Type: OBSERVATIONAL
Condition:
AL Amyloidosis
Recruitment Status: COMPLETED
Sponsor: ...